Bluebird Bio Inc. buy Barclays PLC
Start price
31.12.24
/
50%
€0.37
Target price
31.12.25
€38.48
Performance (%)
-
End price
03.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -1.316% | 0.905% | 14.189% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target raised by analysts at Barclays PLC from $2.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten